CARD10 and neoplasm: In 2012, a semi-quantitative immunohistochemical (IHC) analysis of non-small-cell lung cancer specimens demonstrated that 70% of tumor samples exhibited increased CARMA3 staining relative to normal tissue from the same patients (57).